Emerson’s new gas analysis solutions center, located in Cumbernauld, Scotland, intends to help plants meet sustainability goals.
Emerson announced the opening of a gas analysis solutions facility in Cumbernauld, Scotland on Aug. 29, 2022. The 62,000 ft² facility is designed to help companies reduce their environmental impact.
According to a company press release, the center has access to more than 10 different sensing technologies that can measure more than 60 different gas components. It will also engineer and manufacture Emerson’s Rosemount continuous gas analyzers and gas chromatographers, which are tools designed to improve monitoring emissions, plant safety, quality control, and operational efficiency.
“The mission of our new gas analysis solutions center is to support industrial manufacturers in achieving their decarbonization and environmental sustainability goals, including the deployment of low-carbon fuels and power sources, reducing emissions, and decreasing waste,” said Jon Stokes, group president of Emerson’s measurement solutions business, in the release. “It’s the latest addition to our investment in innovation that will help to achieve a more sustainable future.”
The facility has a gas extraction system, environmental chamber, and an external gas storage to facilitate gas analyzer testing, as well as application research and development. It includes a training space and offers various training options for customers, including in-person and web-based courses. It also has a dedicated area for performing factory acceptance testing and a customer collaboration space.
Source: Emerson
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.